The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor loadDaniele Generali, Alberto Angeli, S. Tedoldi et al.|Bone|2006Cited by 22
<i>DPYD</i> -Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: A Real-World Retrospective StudyFrancesco Schettini, Daniele Generali, Alexandro Membrino et al.|JCO Precision Oncology|2026Cited by 0